RFK Jr. continues to serve as HHS Secretary, directing policy implementation and agency leadership changes into mid-2026 with no formal signals of resignation or removal from the White House. Recent activity includes public events promoting administration health priorities, requests for input on vaccine recommendation frameworks following an executive order, and personnel adjustments at FDA and within HHS itself. Earlier calls for his departure from critics and some former staff have produced no procedural follow-through, while related cabinet departure markets assign him low exit probabilities. Traders price the 75% chance he remains through year-end on this sustained alignment and absence of precipitating developments, consistent with patterns for confirmed officials backed by the administration absent major shifts.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · Updated$24,291 Vol.
$24,291 Vol.
$24,291 Vol.
$24,291 Vol.
An announcement of Robert F. Kennedy Jr. (RFK Jr.)'s resignation/removal before this market's end date will immediately resolve this market to "Yes", regardless of when the announced resignation/removal goes into effect.
The resolution source for this market will be official information from Robert F. Kennedy Jr. (RFK Jr.) and the U.S. government; however, a consensus of credible reporting may also be used.
Market Opened: Mar 19, 2026, 2:02 PM ET
Resolver
0x65070BE91...An announcement of Robert F. Kennedy Jr. (RFK Jr.)'s resignation/removal before this market's end date will immediately resolve this market to "Yes", regardless of when the announced resignation/removal goes into effect.
The resolution source for this market will be official information from Robert F. Kennedy Jr. (RFK Jr.) and the U.S. government; however, a consensus of credible reporting may also be used.
Resolver
0x65070BE91...RFK Jr. continues to serve as HHS Secretary, directing policy implementation and agency leadership changes into mid-2026 with no formal signals of resignation or removal from the White House. Recent activity includes public events promoting administration health priorities, requests for input on vaccine recommendation frameworks following an executive order, and personnel adjustments at FDA and within HHS itself. Earlier calls for his departure from critics and some former staff have produced no procedural follow-through, while related cabinet departure markets assign him low exit probabilities. Traders price the 75% chance he remains through year-end on this sustained alignment and absence of precipitating developments, consistent with patterns for confirmed officials backed by the administration absent major shifts.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · Updated



Beware of external links.
Beware of external links.
Frequently Asked Questions